Vincenzo Nasca

Intratumoral injection of TLR9 agonist promotes an immunopermissive microenvironment transition and causes cooperative antitumor activity in combination with anti-PD1 in pancreatic cancer

Carmine Carbone, Geny Piro, Antonio Agostini et al. · Journal for ImmunoTherapy of Cancer · 2021 · 72 citations · Full text

Life Sciences, Immunology, Oncology +17

Association of immune-related adverse events with the outcomes of immune checkpoint inhibitors in patients with dMMR/MSI-H metastatic colorectal cancer

Vincenzo Nasca, Francesco Barretta, Francesca Corti et al. · Journal for ImmunoTherapy of Cancer · 2023 · 25 citations · Full text

Medicine, Immunology, Oncology +17

Early onset metastatic colorectal cancer patients as a distinctive clinical and molecular phenomenon

Andrea Pretta, Pina Ziranu, Eleonora Perissinotto et al. · British Journal of Cancer · 2024 · 22 citations · Full text

Medicine, Cancer Biology, Oncology +14

Adding fasting‐mimicking diet to first‐line carboplatin‐based chemotherapy is associated with better overall survival in advanced triple‐negative breast cancer patients: A subanalysis of the <scp>NCT03340935</scp> trial

Francesca Ligorio, Riccardo Lobefaro, Giovanni Fucà et al. · International Journal of Cancer · 2023 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Outcomes and a prognostic classifier in patients with microsatellite instability-high metastatic gastric cancer receiving PD-1 blockade

Giovanni Randon, Yu Aoki, Romain Cohen et al. · Journal for ImmunoTherapy of Cancer · 2023 · 20 citations · Full text

Medicine, Immunology, Oncology +17